• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CyclinD1 通过染色质修饰抑制 Dicer 和关键 miRNA 的表达,从而促进肝内胆管癌的进展。

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

机构信息

Department of Biliary-Pancreatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.

Department of Hepatic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China.

出版信息

J Exp Clin Cancer Res. 2019 Oct 7;38(1):413. doi: 10.1186/s13046-019-1415-5.

DOI:10.1186/s13046-019-1415-5
PMID:31590696
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6781400/
Abstract

BACKGROUND

CyclinD1 is crucial for cell cycling and can regulate the expression of Dicer, a crucial regulator of microRNA maturation. However, little is known on how CyclinD1 regulates Dicer and miRNA expression, and the progression of intrahepatic cholangiocarcinoma (ICC).

METHODS

The expression of CyclinD1 and Dicer in non-tumor cholangiocytes, ICC cells and tissues as well as their association with clinicopathological characteristics and survival were examined. The potential mechanisms by which CyclinD1 regulates Dicer and relative miRNA expression were determined by immunoprecipitation, ChIP sequence, BSP and luciferase reporter assays following induction of CyclinD1 over-expression or silencing and Dicer silencing. The impact of CyclinD1 and/or Dicer silencing on the growth of ICC was tested in vivo.

RESULTS

Up-regulated CyclinD1 was associated with down-regulated Dicer expression in ICC tissues and poorer overall survival in patients with ICC. CyclinD1 interacted with the nuclear H3K9me3 and SUV39H1 and bound to the Dicer promoter to increase its CpG island methylation in ICC cells. Functionally, CyclinD1 silencing inhibited the malignancy of ICC cells, which were mitigated partially by Dicer silencing in ICC cells. Dicer silencing down-regulated miR-1914-5p and miR-541-5p expression, which targeted and promoted CyclinD1 and CDK6 expression in ICC cells.

CONCLUSIONS

Our findings uncover that CyclinD1 inhibits Dicer expression by chromatin modification to reduce miR-1914-5p/miR-541-5p expression, which positively-feedback enhances CyclinD1 and CDK6 expression and progression of ICC.

摘要

背景

细胞周期蛋白 D1 对细胞周期至关重要,可调节 Dicer 的表达,Dicer 是 microRNA 成熟的关键调节因子。然而,CyclinD1 如何调节 Dicer 和 miRNA 表达以及肝内胆管癌(ICC)的进展知之甚少。

方法

检测非肿瘤胆管细胞、ICC 细胞和组织中 CyclinD1 和 Dicer 的表达,及其与临床病理特征和生存的关系。通过免疫沉淀、ChIP 序列、BSP 和荧光素酶报告基因检测,在诱导 CyclinD1 过表达或沉默以及 Dicer 沉默后,确定 CyclinD1 调节 Dicer 和相对 miRNA 表达的潜在机制。在体内检测 CyclinD1 和/或 Dicer 沉默对 ICC 生长的影响。

结果

ICC 组织中上调的 CyclinD1 与下调的 Dicer 表达相关,ICC 患者的总生存率较差。CyclinD1 与核 H3K9me3 和 SUV39H1 相互作用,并与 Dicer 启动子结合,增加 ICC 细胞中 CpG 岛的甲基化。功能上,CyclinD1 沉默抑制了 ICC 细胞的恶性程度,而在 ICC 细胞中沉默 Dicer 部分缓解了这种恶性程度。Dicer 沉默下调了 miR-1914-5p 和 miR-541-5p 的表达,这两种 miRNA 靶向并促进了 ICC 细胞中 CyclinD1 和 CDK6 的表达。

结论

我们的研究结果揭示了 CyclinD1 通过染色质修饰抑制 Dicer 表达,从而降低 miR-1914-5p/miR-541-5p 的表达,正向反馈增强了 CyclinD1 和 CDK6 的表达,促进了 ICC 的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/8bec8937ac08/13046_2019_1415_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/b76169a74fd5/13046_2019_1415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/58cc7581b0f0/13046_2019_1415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/18072d556104/13046_2019_1415_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/5653d627706a/13046_2019_1415_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/6805a3dd34ab/13046_2019_1415_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/d1140856c390/13046_2019_1415_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/8bec8937ac08/13046_2019_1415_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/b76169a74fd5/13046_2019_1415_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/58cc7581b0f0/13046_2019_1415_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/18072d556104/13046_2019_1415_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/5653d627706a/13046_2019_1415_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/6805a3dd34ab/13046_2019_1415_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/d1140856c390/13046_2019_1415_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c351/6781400/8bec8937ac08/13046_2019_1415_Fig7_HTML.jpg

相似文献

1
CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.CyclinD1 通过染色质修饰抑制 Dicer 和关键 miRNA 的表达,从而促进肝内胆管癌的进展。
J Exp Clin Cancer Res. 2019 Oct 7;38(1):413. doi: 10.1186/s13046-019-1415-5.
2
Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling.自分泌甲状旁腺素样激素通过增加 ERK/JNK-ATF2-cyclinD1 信号通路促进肝内胆管癌细胞增殖。
J Transl Med. 2017 Nov 25;15(1):238. doi: 10.1186/s12967-017-1342-1.
3
CircRTN4IP1 regulates the malignant progression of intrahepatic cholangiocarcinoma by sponging miR-541-5p to induce HIF1A production.环状RTN4IP1通过吸附miR-541-5p诱导HIF1A产生,从而调控肝内胆管癌的恶性进展。
Pathol Res Pract. 2022 Feb;230:153732. doi: 10.1016/j.prp.2021.153732. Epub 2021 Dec 5.
4
Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.Dicer 通过向核内转移促进 SFRP1 启动子甲基化从而促进胆管癌细胞的肿瘤发生。
Cell Death Dis. 2017 Feb 23;8(2):e2628. doi: 10.1038/cddis.2017.57.
5
LncRNA MT1JP plays a protective role in intrahepatic cholangiocarcinoma by regulating miR-18a-5p/FBP1 axis.长链非编码RNA MT1JP通过调控miR-18a-5p/FBP1轴在肝内胆管癌中发挥保护作用。
BMC Cancer. 2021 Feb 8;21(1):142. doi: 10.1186/s12885-021-07838-0.
6
MicroRNA-191 acts as a tumor promoter by modulating the TET1-p53 pathway in intrahepatic cholangiocarcinoma.MicroRNA-191 通过调节 TET1-p53 通路在肝内胆管癌中发挥肿瘤促进作用。
Hepatology. 2017 Jul;66(1):136-151. doi: 10.1002/hep.29116. Epub 2017 May 18.
7
LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.长链非编码RNA-CCAT1通过抑制miR-152促进肝内胆管癌的迁移、侵袭和上皮-间质转化
Dig Dis Sci. 2017 Nov;62(11):3050-3058. doi: 10.1007/s10620-017-4759-8. Epub 2017 Sep 18.
8
MiR-605 represses PSMD10/Gankyrin and inhibits intrahepatic cholangiocarcinoma cell progression.miR-605 抑制 PSMD10/Gankyrin 并抑制肝内胆管癌细胞进展。
FEBS Lett. 2014 Sep 17;588(18):3491-500. doi: 10.1016/j.febslet.2014.08.008. Epub 2014 Aug 14.
9
miR-182-5p promotes the proliferation and invasion of hilar cholangiocarcinoma cells by inhibiting FBXW7.miR-182-5p 通过抑制 FBXW7 促进肝门部胆管癌细胞的增殖和侵袭。
J Cancer Res Clin Oncol. 2024 Oct 15;150(10):461. doi: 10.1007/s00432-024-05961-6.
10
Expression of transforming growth factor β1 promotes cholangiocarcinoma development and progression.转化生长因子β1的表达促进胆管癌的发生和发展。
Cancer Lett. 2016 Sep 28;380(1):153-62. doi: 10.1016/j.canlet.2016.05.038. Epub 2016 Jun 27.

引用本文的文献

1
Inhibition of colorectal cancer cell growth by downregulation of M2-PK and reduction of aerobic glycolysis by clove active ingredients.通过下调M2-PK抑制结肠癌细胞生长以及通过丁香活性成分减少有氧糖酵解
Front Pharmacol. 2025 Apr 16;16:1552486. doi: 10.3389/fphar.2025.1552486. eCollection 2025.
2
AURKC Promotes Clear Cell Renal Cell Carcinoma Proliferation Through Upregulation of ERp57.极光激酶C通过上调内质网蛋白57促进肾透明细胞癌增殖。
J Cancer. 2025 Jan 13;16(4):1215-1227. doi: 10.7150/jca.103134. eCollection 2025.
3
SUV39H1 epigenetically modulates the MCPIP1-AURKA signaling axis to enhance neuroblastoma tumorigenesis.

本文引用的文献

1
Dicer promotes tumorigenesis by translocating to nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.Dicer 通过向核内转移促进 SFRP1 启动子甲基化从而促进胆管癌细胞的肿瘤发生。
Cell Death Dis. 2017 Feb 23;8(2):e2628. doi: 10.1038/cddis.2017.57.
2
Targeting β-catenin in hepatocellular cancers induced by coexpression of mutant β-catenin and K-Ras in mice.在小鼠中由突变型β-连环蛋白和K-Ras共表达诱导的肝细胞癌中靶向β-连环蛋白
Hepatology. 2017 May;65(5):1581-1599. doi: 10.1002/hep.28975. Epub 2017 Feb 6.
3
Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
SUV39H1 通过表观遗传调控 MCPIP1-AURKA 信号轴以增强神经母细胞瘤的肿瘤发生。
Oncogene. 2024 Nov;43(45):3306-3320. doi: 10.1038/s41388-024-03164-4. Epub 2024 Sep 19.
4
Leishmania highjack host lipid body for its proliferation in macrophages by overexpressing host Rab18 and TRAPPC9 by downregulating miR-1914-3p expression.利什曼原虫通过过度表达宿主 Rab18 和 TRAPPC9 并下调 miR-1914-3p 的表达,劫持宿主脂滴以供其在巨噬细胞中增殖。
PLoS Pathog. 2024 Feb 27;20(2):e1012024. doi: 10.1371/journal.ppat.1012024. eCollection 2024 Feb.
5
[HSDL2 overexpression promotes rectal cancer progression by regulating cancer cell cycle and promoting cell proliferation].[HSDL2过表达通过调节癌细胞周期和促进细胞增殖促进直肠癌进展]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Apr 20;43(4):544-551. doi: 10.12122/j.issn.1673-4254.2023.04.06.
6
miR-4299 inhibits tumor progression in pancreatic cancer through targeting ADAM17.微小RNA-4299通过靶向解聚素金属蛋白酶17抑制胰腺癌的肿瘤进展。
Mol Cell Biochem. 2023 Aug;478(8):1727-1742. doi: 10.1007/s11010-022-04617-8. Epub 2022 Dec 24.
7
A diagnostic miRNA panel to detect recurrence of ovarian cancer through artificial intelligence approaches.通过人工智能方法检测卵巢癌复发的诊断 miRNA 面板。
J Cancer Res Clin Oncol. 2023 Jan;149(1):325-341. doi: 10.1007/s00432-022-04468-2. Epub 2022 Nov 15.
8
The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.H2A.Z-KDM1A 复合物通过定位于核内促进 SFRP1 启动子甲基化,从而促进胆管癌细胞的肿瘤发生。
BMC Cancer. 2022 Nov 11;22(1):1166. doi: 10.1186/s12885-022-10279-y.
9
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation and by targeting MEK1/2.阿折地平通过靶向MEK1/2抑制食管鳞状细胞癌增殖。
Mol Ther Oncolytics. 2022 Sep 26;27:61-72. doi: 10.1016/j.omto.2022.09.007. eCollection 2022 Dec 15.
10
Mechanisms Controlling MicroRNA Expression in Tumor.肿瘤中 miRNA 表达调控的机制
Cells. 2022 Sep 13;11(18):2852. doi: 10.3390/cells11182852.
肝硬化患者肝内胆管细胞癌:钆塞酸增强磁共振成像和动态 CT 鉴别诊断肝细胞癌。
Radiology. 2017 Mar;282(3):771-781. doi: 10.1148/radiol.2016160639. Epub 2016 Oct 31.
4
DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1.DICER1调控p53诱导的癌症抑制过程中let-7的表达水平需要细胞周期蛋白D1。
J Cell Mol Med. 2015 Jun;19(6):1357-65. doi: 10.1111/jcmm.12522. Epub 2015 Feb 20.
5
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.肝内胆管癌诊断和管理指南
J Hepatol. 2014 Jun;60(6):1268-89. doi: 10.1016/j.jhep.2014.01.021. Epub 2014 Mar 27.
6
Cholangiocarcinoma.胆管癌。
Lancet. 2014 Jun 21;383(9935):2168-79. doi: 10.1016/S0140-6736(13)61903-0. Epub 2014 Feb 26.
7
Cyclin D1 induction of Dicer governs microRNA processing and expression in breast cancer.周期素 D1 诱导 Dicer 调控乳腺癌中的 microRNA 加工和表达。
Nat Commun. 2013;4:2812. doi: 10.1038/ncomms3812.
8
Cancer genome landscapes.肿瘤基因组图谱。
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
9
Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma.转录组谱分析揭示了肝内胆管癌中肝干细胞样基因特征和 miR-200c 与上皮-间充质转化的相互作用。
Hepatology. 2012 Nov;56(5):1792-803. doi: 10.1002/hep.25890. Epub 2012 Aug 22.
10
Nuclear pore complex protein mediated nuclear localization of dicer protein in human cells.核孔复合体蛋白介导的人类细胞中 Dicer 蛋白的核定位。
PLoS One. 2011;6(8):e23385. doi: 10.1371/journal.pone.0023385. Epub 2011 Aug 15.